5th Annual NASH Summit

Deepening Understanding of Early, Translational and Late Stage Clinical Science to Support NASH Candidate Entry to Market

Are you ready to discover the knowledge you need to radically transform your NASH drug development strategy? Then look no further – returning with a revitalized agenda and re-energized speaker faculty, the NASH Summit is back!

Masterfully combining the hottest insights on NASH from 65+ strong speaker faculty, including 45+ brand new speakers from the FDA, EMA, Takeda, Eli Lilly, Gilead, Pfizer, AstraZeneca, Ionis, Novo Nordisk and more, the 5th NASH Summit is your best opportunity to unite with fellow NASH drug developers to gain critical updates on the trailblazing research you need to meaningfully reassess your therapeutic approach and optimize your pipeline strategy for the future.

From evaluating the potential of the gut-liver axis as a therapeutic target and analyzing the nuances of designing models which accurately illustrate cirrhosis complications to discovering which physiological factors you must monitor to maximize the success of your clinical trials, this is the only end-to-end forum dedicated to helping industry translate scientific advancements to actionable insights in order to achieve more innovative and clinically effective NASH drug development.

Join 3 streams, a focused seminar day and 6 workshops of unparalleled content to keep your companies interests in NASH up to date and aligned with the new cadence of this exciting field.

5th NASH Summit 2021
November 29 ‐ December 2, 2021


Hot topics